logo

Dermira Inc. (DERM)



Trade DERM now with
  Date
  Headline
10/13/2017 8:04:11 AM Dermira Shows New Long-Term Safety Data For Glycopyrronium Tosylate In Primary Axillary Hyperhidrosis
8/8/2017 7:33:45 AM Dermira Enters Licensing Agreement With F. Hoffmann-La Roche Ltd And Genentech
5/10/2017 9:38:45 PM Dermira Prices Offering Of $250 Mln Of 3.00% Convertible Senior Notes
3/21/2017 7:36:03 AM Dermira Presents New Data Highlighting Patient Outcomes In Axillary Hyperhidrosis At Maui Derm Meeting
3/4/2017 9:16:52 PM Dermira: CIMZIA Shows Significant Improvements In Chronic Plaque Psoriasis
3/1/2017 7:50:41 PM Dermira Prices Underwritten Public Offering Of 5 Mln Shares At $33.70/shr
1/19/2017 2:32:56 AM UCB, Dermira: Final CIMZIA Phase 3 Trial Meets Primary Efficacy Endpoint In Chronic Plaque Psoriasis Patients
1/4/2017 4:06:27 PM Dermira Elects Emmanuel Caeymaex To Board Of Directors
1/3/2017 7:35:19 AM Dermira Says Begins Phase 3 Clinical Program In Acne
12/8/2016 4:24:20 AM Dermira Does It Again!
12/8/2016 2:04:02 AM UCB, Dermira Report That CIMZIA Showed Statistically Significant Improvements For Both Co-primary Endpoints
10/21/2016 7:36:55 AM Dermira Presents Data From DRM01 Phase 2b Clinical Program At Annual Meeting For Dermatologists